Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Allografting

Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma

Abstract

Adult T-cell leukaemia/lymphoma (ATLL) is a highly aggressive haematological malignancy. More than 40 cases of ATLL treated by allogeneic bone marrow transplantation (BMT) from sibling donors have been reported, while there have been only a few cases of unrelated BMT for treatment of this disease. We began performing allogeneic BMT from unrelated donors in 1999 to improve the outcome of ATLL patients with no suitable sibling donors. Eight ATLL patients underwent unrelated BMT; five received the conventional conditioning regimen consisting of cyclophosphamide and total body irradiation, while three received a reduced-intensity preparative regimen. Two patients died due to encephalopathy of unknown aetiology on days 10 and 35, and one patient died due to progression of ATLL 25 months after BMT. Five patients are currently alive and disease-free at a median of 20 months after BMT. Proviral human T-lymphotropic virus type-I (HTLV-I) DNA load in peripheral blood mononuclear cells (PBMCs) was assessed in four cases before and after BMT. HTLV-I proviral DNA load was reduced significantly after transplantation. Unrelated BMT is feasible for treatment of ATLL. Further studies in a larger number of cases are required to determine the optimal conditioning regimen and stem cell source.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Tsukasaki K, Maeda T, Arimura K, Taguchi J, Fukushima T, Miyazaki Y et al. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature. Bone Marrow Transplant 1999; 23: 87–89.

    Article  CAS  Google Scholar 

  2. Tsukasaki K, Tobinai K, Shimoyama M, Kozuru M, Uike N, Yamada Y et al. Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109). Int J Hematol 2003; 77: 164–170.

    Article  CAS  Google Scholar 

  3. Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 2001; 113: 375–382.

    Article  CAS  Google Scholar 

  4. Hamaki T, Kami M, Igarashi M, Kusumi E, Arase Y, Ishibashi T et al. Non-myeloablative hematopoietic stem cell transplantation for the treatment of adult T-cell lymphoma in a patient with advanced hepatic impairment. Leuk Lymph 2003; 44: 703–708.

    Article  CAS  Google Scholar 

  5. Kami M, Hamaki T, Miyakoshi S, Murashige N, Kanda Y, Tanosaki R et al. Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma. Br J Haematol 2003; 120: 304–309.

    Article  Google Scholar 

  6. Abe Y, Yashiki S, Choi I, Hara K, Matsushima T, Nishimura J et al. Eradication of virus-infected T-cells in a case of adult T-cell leukemia/lymphoma by nonmyeloablative peripheral blood stem cell transplantation with conditioning consisting of low-dose total body irradiation and pentostatin. Int J Hematol 2002; 76: 91–93.

    Article  Google Scholar 

  7. Utsunomiya A, Miyazaki Y, Takatsuka Y, Hanada S, Uozumi K, Yashiki S et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 15–20.

    Article  CAS  Google Scholar 

  8. Tajima K, Amakawa R, Uehira K, Matsumoto N, Shimizu T, Miyazaki Y et al. Adult T-cell leukemia successfully treated with allogeneic bone marrow transplantation. Int J Hematol 2000; 71: 290–293.

    CAS  Google Scholar 

  9. Hara M, Azuma D, Nawada Y, Kojima K, Sawada T, Kamioka J et al. Case of adult T-cell leukemia (ATL) with homologous bone marrow transplantation. Nippon Naika Gakkai Zasshi 1999; 88: 334–335.

    Article  CAS  Google Scholar 

  10. Obama K, Tara M, Sao H, Taji H, Morishima Y, Mougi H et al. Allogenic bone marrow transplantation as a treatment for adult T-cell leukemia. Int J Hematol 1999; 69: 203–205.

    CAS  PubMed  Google Scholar 

  11. Borg A, Yin JA, Johnson PR, Tosswill J, Saunders M, Morris D et al. Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation. Br J Haematol 1996; 94: 713–715.

    Article  CAS  Google Scholar 

  12. Sobue R, Yamauchim T, Miyamura K, Sao H, Tahara T, Yoshikawa H et al. Treatment of adult T cell leukemia with mega-dose cyclophosphamide and total body irradiation followed by allogeneic bone marrow transplantation. Bone Marrow Transplant 1987; 2: 441–444.

    CAS  Google Scholar 

  13. Ishikawa T . Current status of therapeutic approaches to adult T-cell leukemia. Int J Hematol 2003; 78: 304–311.

    Article  Google Scholar 

  14. Ogata M, Ogata Y, Imamura T, Ohtsuka E, Kikuchi H, Utsunomiya A et al. Successful bone marrow transplantation from an unrelated donor in a patient with adult T cell leukemia. Bone Marrow Transplant 2002; 30: 699–701.

    Article  CAS  Google Scholar 

  15. Izutsu K, Kanda Y, Ohno H, Sao H, Ogawa H, Miyazaki Y et al. Unrelated bone marrow transplantation for non-Hodgkin lymphoma: a study from the Japan Marrow Donor Program. Blood 2004; 103: 1955–1960.

    Article  CAS  Google Scholar 

  16. Shimoyama M . Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984–87). Br J Haematol 1991; 79: 428–437.

    Article  CAS  Google Scholar 

  17. Nakamura N, Arakaki Y, Sunagawa H, Shiohira Y, Uehara H, Miyasato T et al. Influence of immunosuppression in HTLV-1-positive renal transplant recipients. Transplant Proc 1998; 30: 1324–1326.

    Article  CAS  Google Scholar 

  18. Imirizaldu JJ, Esteban JC, Axpe IR, Concha TP, Juanes FV, Susaeta IA et al. Post-transplantation HTLV-1 myelopathy in three recipients from a single donor. J Neurol Neurosurg Psychiatry 2003; 74: 1080–1084.

    Article  Google Scholar 

  19. Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Hanabuchi S, Masuda M et al. Graft-versus-Tax Response in Adult T-Cell Leukemia Patients after Hematopoietic Stem Cell Transplantation. Cancer Res 2004; 64: 391–399.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to Dr K Togitani for providing further information on Patient no. 8.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K Nakase.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakase, K., Hara, M., Kozuka, T. et al. Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma. Bone Marrow Transplant 37, 41–44 (2006). https://doi.org/10.1038/sj.bmt.1705197

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705197

Keywords

This article is cited by

Search

Quick links